Mapping brain cells affected by Alzheimer's disease

Atlas for neuronal and glial cell types selectively vulnerable to proteinopathies during progression of Alzheimer's Disease

NIH-funded research Salk Institute for Biological Studies · NIH-10849836

This study looks at how specific brain cells are affected by Alzheimer's disease and why some areas of the brain are more impacted than others, which can help us understand the different symptoms people experience and find new ways to treat the disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionSalk Institute for Biological Studies NIH-funded
Lab location1 site (La Jolla, UNITED STATES)
Project IDNIH-10849836 on NIH RePORTER

What this research studies

This research investigates how certain types of brain cells, both neurons and glial cells, are selectively affected by Alzheimer's disease as it progresses. By examining the mechanisms behind this vulnerability, the study aims to understand why some brain regions are more impacted than others, which can lead to different symptoms in patients. The approach involves analyzing the interactions between these cells and the proteins associated with Alzheimer's, focusing on their responses over time and across various brain regions. This could provide insights into the disease's progression and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk due to genetic factors or age.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for Alzheimer's disease, potentially slowing its progression or alleviating symptoms.

How similar studies have performed: Previous research has shown promising results in understanding the cellular mechanisms of Alzheimer's, suggesting that this approach could yield valuable insights.

Where this research is happening

La Jolla, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.